Vaso (OTCMKTS:VASO) and ENDRA Life Sciences (NASDAQ:NDRA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, analyst recommendations and valuation.

Institutional and Insider Ownership

18.7% of ENDRA Life Sciences shares are owned by institutional investors. 9.1% of Vaso shares are owned by insiders. Comparatively, 12.7% of ENDRA Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Vaso and ENDRA Life Sciences’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Vaso -4.65% -46.63% -6.69%
ENDRA Life Sciences N/A -360.26% -249.53%

Analyst Recommendations

This is a summary of current ratings and recommmendations for Vaso and ENDRA Life Sciences, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vaso 0 0 0 0 N/A
ENDRA Life Sciences 0 0 0 0 N/A

Volatility & Risk

Vaso has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Comparatively, ENDRA Life Sciences has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500.

Earnings & Valuation

This table compares Vaso and ENDRA Life Sciences’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Vaso $73.98 million 0.08 -$4.53 million N/A N/A
ENDRA Life Sciences $10,000.00 1,014.32 -$9.80 million N/A N/A

Vaso has higher revenue and earnings than ENDRA Life Sciences.

Summary

Vaso beats ENDRA Life Sciences on 5 of the 9 factors compared between the two stocks.

Vaso Company Profile

Vaso Corporation operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging capital equipment, GEHC service agreements, and GEHC and third party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices. This segment provides Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for physiological signals, such as ECG and blood pressure; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsaion therapy systems that are used for non-invasive, outpatient treatment of ischemic heart disease, as well as in-service and training support. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was founded in 1987 and is headquartered in Plainview, New York.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. It also offers Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan.

Receive News & Ratings for Vaso Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vaso and related companies with MarketBeat.com's FREE daily email newsletter.